Peginterferon and ribavirin for chronic hepatitis C

N Engl J Med. 2006 Dec 7;355(23):2444-51. doi: 10.1056/NEJMct061675.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects
  • Antiviral Agents / economics
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepacivirus / drug effects*
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / pharmacology
  • Polyethylene Glycols / therapeutic use*
  • Practice Guidelines as Topic
  • RNA, Viral / blood
  • Recombinant Proteins
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a